$MBX Biosciences has generated 8 mentions from 2 distinct FinTwit voices over the past 12 months, with the first mention appearing on September 19, 2025. Biotech analyst @adamfeuerstein accounts for 6 of these mentions, while Japanese investment-focused VTuber @yasutaketin contributed 2 mentions. The most recent discussion occurred on December 23, 2025, when @yasutaketin highlighted $MBX as a biopharmaceutical company developing innovative peptide therapies for rare and endocrine diseases and noted it among their top-performing long positions.